LakeShore Biopharma Co., Ltd (LSB)
USD 1.19
(-4.8%)
USD 1.19
(-4.8%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 455.72 Million CNY | -14.63% |
| 2022 | 533.84 Million CNY | 38.34% |
| 2021 | 385.88 Million CNY | 95.52% |
| 2020 | 197.35 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | 4.75 Million USD | -74.8% |
| 2023 FY | 455.72 Million CNY | -14.63% |
| 2023 Q3 | 18.88 Million USD | -76.18% |
| 2023 Q2 | 79.31 Million CNY | -43.99% |
| 2023 Q1 | 141.59 Million CNY | 1045.59% |
| 2022 Q3 | 20.75 Million USD | -2.54% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | 21.29 Million USD | 0.0% |
| 2022 FY | 533.84 Million CNY | 38.34% |
| 2022 Q4 | 12.35 Million USD | -40.44% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 385.88 Million CNY | 95.52% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2020 FY | 197.35 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 469924.696% |
| Psyence Biomedical Ltd. | -240.00 USD | 189887581.25% |
| XOMA Corporation | 3.86 Million USD | -11703.418% |
| Mesoblast Limited | -9.81 Million USD | 4743.199% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -236.906% |
| Aptorum Group Limited | -1.11 Million USD | 40984.082% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 10138697.442% |
| HilleVax, Inc. | -2.15 Million USD | 21237.753% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 6520.54% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 1562.189% |
| Precision BioSciences, Inc. | 40.47 Million USD | -1026.038% |
| Dyadic International, Inc. | 922.95 Thousand USD | -49277.16% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 310120.378% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 529.436% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -2063.857% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -107383.48% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -1001.169% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -381.119% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 5346.114% |
| IGM Biosciences, Inc. | -211.66 Million USD | 315.312% |
| Opthea Limited | 21.72 Thousand USD | -2098104.213% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -113265.66% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -18615.809% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -14955.499% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -280.558% |
| NextCure, Inc. | -3.68 Million USD | 12470.52% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 3511.702% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 37923.68% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -2172.741% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -194.416% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 564.003% |
| Senti Biosciences, Inc. | -2.68 Million USD | 17085.835% |
| Apollomics, Inc. | 127 Thousand USD | -358742.484% |
| PureTech Health plc | -1.6 Million USD | 28529.816% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 1673.219% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -56724.184% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 512.466% |
| ChromaDex Corporation | 50.78 Million USD | -797.46% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -278.281% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 1105.471% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 7380.031% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 564.258% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -379674.963% |
| Fortress Biotech, Inc. | 57.85 Million USD | -687.738% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 1148.547% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1981534.587% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -350461.504% |
| Celcuity Inc. | -142.77 Thousand USD | 319301.212% |
| ContextLogic Inc. | 59 Million USD | -672.424% |
| GH Research PLC | -315 Thousand USD | 144776.176% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -2649.17% |
| Cassava Sciences, Inc. | -89.42 Million USD | 609.634% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -117054.23% |
| ImmuCell Corporation | 4.39 Million USD | -10266.254% |
| Amarin Corporation plc | 165.54 Million USD | -175.297% |
| TG Therapeutics, Inc. | 219.1 Million USD | -107.993% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 22932.162% |
| Acelyrin, Inc. | -115 Thousand USD | 396386.917% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -6385.413% |
| Novavax, Inc. | 639.93 Million USD | 28.785% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -88391.253% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 86.591% |
| AnaptysBio, Inc. | 14.78 Million USD | -2983.215% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 80475.653% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 36355.366% |
| AbCellera Biologics Inc. | 38.02 Million USD | -1098.501% |
| CorMedix Inc. | -205.56 Thousand USD | 221799.514% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -1763.85% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 6513.623% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 95.967% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 96135.14% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 4382118.798% |
| Soligenix, Inc. | 97.31 Thousand USD | -468223.165% |
| Century Therapeutics, Inc. | -10.8 Million USD | 4316.208% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -89.308% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 88292.256% |
| Kura Oncology, Inc. | -849 Thousand USD | 53778.44% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 12933.848% |
| Ardelyx, Inc. | 106.66 Million USD | -327.27% |
| Ainos, Inc. | -253.73 Thousand USD | 179710.045% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 779.14% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Prothena Corporation plc | -129.2 Million USD | 452.729% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -360.152% |
| Autolus Therapeutics plc | -4.86 Million USD | 9463.673% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -803.797% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 271367.83% |
| Celularity Inc. | 6.75 Million USD | -6646.557% |
| Rallybio Corporation | -150 Thousand USD | 303919.97% |
| GRI Bio, Inc. | 10.84 Million USD | -4103.763% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -17842.223% |
| Omeros Corporation | -69.77 Million USD | 753.105% |
| INmune Bio, Inc. | 155 Thousand USD | -293919.326% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -635.772% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 30355.107% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 70379.458% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 1556873.775% |
| Humacyte, Inc. | -76.55 Million USD | 695.336% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 145700.625% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -382.453% |
| Immunocore Holdings plc | 248.39 Million USD | -83.473% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 3104.351% |
| Verastem, Inc. | -62 Thousand USD | 735148.315% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 174709.178% |
| Histogen Inc. | 3.76 Million USD | -11991.535% |
| Surrozen, Inc. | -27.23 Million USD | 1773.632% |
| Blueprint Medicines Corporation | 236.58 Million USD | -92.629% |
| Organovo Holdings, Inc. | -5.38 Million USD | 8556.67% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | -756 Thousand USD | 60381.74% |
| MEI Pharma, Inc. | 49.32 Million USD | -823.896% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -7412.334% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 678966.626% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 32058.622% |
| Summit Therapeutics Inc. | -2.05 Million USD | 22330.73% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 9598.332% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -1468.508% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -312471.986% |
| Turnstone Biologics Corp. | 16.5 Million USD | -2660.996% |
| Pulmatrix, Inc. | -8.22 Million USD | 5644.16% |
| Synaptogenix, Inc. | -6347.00 USD | 7180341.925% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 893688.147% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -182.422% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 114318.034% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 214.277% |
| Cytokinetics, Incorporated | -322.59 Million USD | 241.271% |
| Exelixis, Inc. | 1.75 Billion USD | 74.072% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 506.318% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -34.799% |
| Evogene Ltd. | 1.39 Million USD | -32475.408% |
| Replimune Group, Inc. | -2.65 Million USD | 17264.97% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 795079.512% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 41230.862% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 384711.452% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | -41030.862% |
| Avid Bioservices, Inc. | 7.31 Million USD | -6127.52% |
| Insmed Incorporated | 239.63 Million USD | -90.177% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -91781.039% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 32909.932% |
| Sagimet Biosciences Inc. | 2 Million USD | -22686.498% |
| MediWound Ltd. | 3.57 Million USD | -12637.003% |
| MiMedx Group, Inc. | 266.84 Million USD | -70.786% |
| OmniAb, Inc. | 14.66 Million USD | -3007.179% |
| Alector, Inc. | -95.05 Million USD | 579.448% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -262.782% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 47.758% |
| Mereo BioPharma Group plc | 7.42 Million USD | -6036.951% |
| Zai Lab Limited | 170.9 Million USD | -166.66% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -456.603% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 3797849.625% |
| Aura Biosciences, Inc. | -1.29 Million USD | 35291.502% |
| Immunic, Inc. | -111 Thousand USD | 410667.527% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 18618.08% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -2774.542% |
| Veracyte, Inc. | 248.14 Million USD | -83.652% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 106.521% |
| FibroGen, Inc. | 128.9 Million USD | -253.542% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Allakos Inc. | -6.14 Million USD | 7521.103% |
| scPharmaceuticals Inc. | 9.78 Million USD | -4558.863% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 760.516% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 4.237% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 80803283.511% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 3994927.796% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 4006.184% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -28.25% |
| Precigen, Inc. | 106 Thousand USD | -429833.92% |
| Fortrea Holdings Inc. | 424 Million USD | -7.483% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 628.892% |
| Incyte Corporation | 3.44 Billion USD | 86.755% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 898267.038% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -2980.505% |
| XBiotech Inc. | -1.74 Million USD | 26231.305% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -3557.544% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 41230.862% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | -89.134% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 1571582.603% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 1080.676% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 703.344% |
| Agenus Inc. | 139.61 Million USD | -226.419% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 11416.756% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -520.86% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -2612.194% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | -17.142% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 1017.941% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -233958.156% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -39.473% |
| UroGen Pharma Ltd. | 73.35 Million USD | -521.292% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 4124.517% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1807.237% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -8439343.611% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 241226.96% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 682054.831% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -11149.814% |
| Chimerix, Inc. | 324 Thousand USD | -140557.394% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 86905.706% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 1031443.249% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 206334.113% |
| Pluri Inc. | 322 Thousand USD | -141431.042% |
| Cue Biopharma, Inc. | -32.6 Million USD | 1497.645% |
| MeiraGTx Holdings plc | 287 Thousand USD | -158690.925% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -78995.204% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 23016764.394% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -630.547% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 4463.158% |
| CalciMedica, Inc. | -58 Thousand USD | 785841.302% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 16124.26% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 1576.527% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 39051.278% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 3994927.796% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -16319.24% |
| Nutriband Inc. | 862.1 Thousand USD | -52762.465% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 133745.148% |
| Vor Biopharma Inc. | -3.49 Million USD | 13150.686% |
| Roivant Sciences Ltd. | 109.23 Million USD | -317.201% |
| ProKidney Corp. | -3.16 Million USD | 14480.876% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 1137.826% |
| Daré Bioscience, Inc. | 2.76 Million USD | -16355.185% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -6546.2% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 26458.008% |
| Bicycle Therapeutics plc | -129.52 Million USD | 451.861% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 679.286% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 1381099.864% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 214.028% |
| Atai Life Sciences N.V. | -5000.00 USD | 9114699.1% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 374081.368% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 474818.703% |
| MediciNova, Inc. | 979.7 Thousand USD | -46417.059% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 640.483% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 482073.407% |
| GeoVax Labs, Inc. | -20.72 Million USD | 2299.388% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -703.927% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -86.366% |
| Biomea Fusion, Inc. | -4.2 Million USD | 10948.13% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | -3.73 Million USD | 12311.414% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 147109.663% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 9114699.1% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 696.716% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -113.222% |
| bluebird bio, Inc. | -4.03 Million USD | 11408.436% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 48530.388% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -45066.497% |
| Imunon, Inc. | -720 Thousand USD | 63395.388% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 76.069% |
| BioAtla, Inc. | -103.73 Million USD | 539.338% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 287.683% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 146636.963% |
| DBV Technologies S.A. | 15.72 Million USD | -2797.571% |
| Fortress Biotech, Inc. | 57.85 Million USD | -687.738% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 351.218% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 750.253% |
| aTyr Pharma, Inc. | -2.38 Million USD | 19184.169% |
| Viridian Therapeutics, Inc. | -1 Million USD | 45311.305% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -3505614938.462% |
| Galecto, Inc. | -830 Thousand USD | 55007.223% |
| Akari Therapeutics, Plc | -4000.00 USD | 11393348.875% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 28.445% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -40626.538% |
| Entera Bio Ltd. | -56 Thousand USD | 813903.491% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -240.636% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 79912.602% |
| Xencor, Inc. | -85.26 Million USD | 634.518% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -17605.126% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 1258.351% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 45616.737% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -156.253% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -233958.156% |
| Portage Biotech Inc. | -54 Thousand USD | 844044.361% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 482073.407% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 120983.277% |
| OncoCyte Corporation | 413 Thousand USD | -110246.236% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 205283863.514% |
| Purple Biotech Ltd. | -196 Thousand USD | 232615.283% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -4981.735% |
| Onconetix, Inc. | -1.12 Million USD | 40531.521% |
| MacroGenics, Inc. | 50.52 Million USD | -801.953% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 3037489.729% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 68323.047% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -2293.163% |
| Prime Medicine, Inc. | -147.9 Million USD | 408.123% |
| Aditxt, Inc. | -111.66 Thousand USD | 408240.744% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 6071512.746% |
| Savara Inc. | -44.26 Million USD | 1129.619% |
| Curis, Inc. | 9.81 Million USD | -4545.092% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 365303.349% |
| Adagene Inc. | 18.11 Million USD | -2416.248% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 199981.559% |
| BeiGene, Ltd. | 2.07 Billion USD | 78.078% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -74732.505% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 318122.871% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -225.052% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1615132.798% |
| SciSparc Ltd. | 2.19 Million USD | -20652.73% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1615132.798% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 49906.552% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1819453.886% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 1471050.729% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -5592.355% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -734.38% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 85124.245% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 69.976% |
| ADMA Biologics, Inc. | 88.21 Million USD | -416.595% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -315.16% |
| Clene Inc. | 533 Thousand USD | -85402.806% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 510.095% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 12801.504% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 47720.685% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -22824.042% |
| Adicet Bio, Inc. | -6.09 Million USD | 7573.433% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -815.029% |
| Absci Corporation | -41.84 Million USD | 1188.986% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -93287.286% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -188.736% |
| Surrozen, Inc. | -27.23 Million USD | 1773.632% |
| Generation Bio Co. | -73.91 Million USD | 716.593% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 687.296% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 104386.031% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 1072.971% |
| Invivyd, Inc. | -2.02 Million USD | 22571.891% |
| Cingulate Inc. | -582.91 Thousand USD | 78280.8% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 251.485% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 440682.721% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 6020310.766% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -372.906% |
| Jaguar Health, Inc. | 7.72 Million USD | -5800.181% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -363.668% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -5689.988% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 51828.712% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 33.05% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -1790.275% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 234630.329% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 1.37 Million USD | -33116.469% |
| Innoviva, Inc. | 261.06 Million USD | -74.566% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 949.197% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -1464.523% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 54613.153% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -446.341% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -623231.266% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -757.248% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 363.142% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 129201.97% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 1470196.629% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 2413.467% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 46226.514% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 808963.645% |
| AlloVir, Inc. | -398 Thousand USD | 114605.014% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 44259.879% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -45.289% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 156171.902% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 68734.029% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -11256.341% |
| ImmunityBio, Inc. | -17.89 Million USD | 2647.401% |
| Korro Bio, Inc. | -3.63 Million USD | 12654.544% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 570.067% |
| Kineta, Inc. | 5.43 Million USD | -8288.182% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 260750.958% |
| BioVie Inc. | -229.37 Thousand USD | 198781.627% |
| Codexis, Inc. | 57.33 Million USD | -694.869% |
| Celularity Inc. | 6.75 Million USD | -6646.557% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 121952.929% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -900730.115% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1856.388% |
| Cibus, Inc. | 1.42 Million USD | -31948.52% |
| Annexon, Inc. | -3.26 Million USD | 14049.494% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 1191.909% |
| Moderna, Inc. | 2.15 Billion USD | 78.852% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 41.462% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 22395.986% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -71107.805% |
| Immix Biopharma, Inc. | -5468.00 USD | 8334590.764% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -163.496% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 7424.493% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -337.785% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 24085.787% |
| Alkermes plc | 1.37 Billion USD | 66.848% |
| Arcellx, Inc. | 108.27 Million USD | -320.885% |
| Moolec Science SA | -143.3 Thousand USD | 318113.995% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 1507.921% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -13764.617% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -475.388% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 2254.548% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 750.207% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 24212.696% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 12617208.389% |
| Humacyte, Inc. | -76.55 Million USD | 695.336% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 1176.918% |
| Geron Corporation | -123.5 Million USD | 469.003% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -10309.547% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 1.79 Billion USD | 74.596% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -196852.325% |
| Notable Labs, Ltd. | 113 Thousand USD | -403200.845% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 509.042% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 48113.321% |
| IN8bio, Inc. | -2.5 Million USD | 18321.909% |
| 89bio, Inc. | -273 Thousand USD | 167034.049% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 1519199.85% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -24375.293% |
| Acasti Pharma Inc. | -11 Thousand USD | 4143099.591% |
| Genelux Corporation | -848 Thousand USD | 53841.74% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 370612.159% |
| Liquidia Corporation | 14.6 Million USD | -3021.438% |
| Mustang Bio, Inc. | -2.22 Million USD | 20582.245% |
| Immunovant, Inc. | -231 Thousand USD | 197385.695% |
| Vericel Corporation | 135.57 Million USD | -236.144% |
| Quantum-Si incorporated | 488 Thousand USD | -93287.286% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 920.263% |
| XOMA Corporation | 3.86 Million USD | -11703.418% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 2374.556% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 222823.408% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 70379.458% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 42532.957% |
| Vaxcyte, Inc. | -75 Million USD | 707.64% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 372.058% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 119714.161% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 2172.725% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -568.952% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 23375.279% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 54678.438% |
| PepGen Inc. | -1.18 Million USD | 38590.706% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 358942.484% |
| United Therapeutics Corporation | 2.07 Billion USD | 77.984% |
| Solid Biosciences Inc. | -76.56 Million USD | 695.235% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 551944.756% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | 59739.745% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -687648.936% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 11660.741% |
| Belite Bio, Inc | -399 Thousand USD | 114318.034% |
| Pharming Group N.V. | 220.1 Million USD | -107.052% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 104998.378% |
| Pyxis Oncology, Inc. | -2 Million USD | 22886.498% |
| uniQure N.V. | 2.21 Million USD | -20474.716% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 555868.238% |
| GeoVax Labs, Inc. | -20.72 Million USD | 2299.388% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 594.987% |
| Altimmune, Inc. | -65.37 Million USD | 797.123% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 42532.957% |
| Peak Bio, Inc. | 367.76 Thousand USD | -123817.447% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 104386.031% |
| Benitec Biopharma Inc. | 108 Thousand USD | -421872.181% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -25.882% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 4534275.256% |
| Compugen Ltd. | 31.45 Million USD | -1348.832% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -40067.283% |
| argenx SE | 1.1 Billion USD | 58.887% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -1758.908% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 2090.348% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 584369.173% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 37982.789% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 86576.272% |
| PolyPid Ltd. | -1.82 Million USD | 25112.621% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 383066.349% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 9640.087% |
| Forte Biosciences, Inc. | -9000.00 USD | 5063766.167% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -18343.139% |
| Instil Bio, Inc. | -4.75 Million USD | 9682.211% |
| Elevation Oncology, Inc. | -39 Thousand USD | 1168638.346% |
| Immunome, Inc. | -8.9 Million USD | 5216.537% |
| Verona Pharma plc | -679.62 Thousand USD | 67156.189% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 111790.306% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 260517.117% |
| Shattuck Labs, Inc. | -2.38 Million USD | 19208.174% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 19033.525% |
| Design Therapeutics, Inc. | -537 Thousand USD | 84965.913% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 106828.327% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -21136.251% |
| Achilles Therapeutics plc | -4.73 Million USD | 9732.303% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -1059737.105% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 55541.6% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 3463619.95% |
| Beam Therapeutics Inc. | -59.67 Million USD | 863.725% |
| Moolec Science SA | -143.3 Thousand USD | 318113.995% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 9114699.1% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -2015.247% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 153544.429% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 4864.06% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -3136.718% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 17158.775% |
| Athira Pharma, Inc. | -969 Thousand USD | 47130.955% |
| HCW Biologics Inc. | -574.82 Thousand USD | 79381.651% |
| XOMA Corporation | 3.86 Million USD | -11703.418% |
| NeurAxis, Inc. | 2.15 Million USD | -21030.853% |
| Lumos Pharma, Inc. | 2 Million USD | -22607.023% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 260517.117% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 431356.167% |
| Nektar Therapeutics | 53.47 Million USD | -752.182% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 37982.789% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -1339.507% |
| Arvinas, Inc. | 71.8 Million USD | -534.721% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Palisade Bio, Inc. | 246 Thousand USD | -185156.079% |
| Nutriband Inc. | 862.1 Thousand USD | -52762.465% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 1100.549% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 1381099.864% |
| Merus N.V. | -83.46 Million USD | 646.039% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 825.974% |
| Neurogene Inc. | -3.26 Million USD | 14070.875% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -227.075% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 828699.918% |
| CervoMed Inc. | -1.29 Million USD | 35328.853% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 12443.715% |
| Sesen Bio, Inc. | 40 Million USD | -1039.325% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 141631.042% |
| Rezolute, Inc. | -36 Thousand USD | 1266016.542% |
| Clene Inc. | 533 Thousand USD | -85402.806% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 35493087.15% |
| BeyondSpring Inc. | 1.75 Million USD | -25926.839% |
| Synlogic, Inc. | -1.92 Million USD | 23786.588% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 1231802.581% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 7297.251% |
| Peak Bio, Inc. | 367.76 Thousand USD | -123817.447% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 2503.259% |
| Krystal Biotech, Inc. | 47.6 Million USD | -857.315% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -223.004% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -8969.253% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 17701.059% |
| MannKind Corporation | 136.19 Million USD | -234.626% |
| Ikena Oncology, Inc. | -50.49 Million USD | 1002.579% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -318.816% |
| Gossamer Bio, Inc. | -4.38 Million USD | 10492.929% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 180945.22% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 9114699.1% |
| Legend Biotech Corporation | 140.92 Million USD | -223.376% |
| Mural Oncology plc | -2.56 Million USD | 17853.407% |
| Disc Medicine, Inc. | -100 Thousand USD | 455829.955% |
| Champions Oncology, Inc. | 20.75 Million USD | -2095.866% |
| REGENXBIO Inc. | 53.02 Million USD | -759.398% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 8607.261% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 236996.663% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 26412.353% |
| Vaxart, Inc. | -60.76 Million USD | 850.012% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 173526.423% |
| Cellectis S.A. | 18 Thousand USD | -2531733.083% |
| Longeveron Inc. | 221 Thousand USD | -206112.649% |
| Repare Therapeutics Inc. | -80.07 Million USD | 669.164% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 58.304% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 35318.698% |
| Revolution Medicines, Inc. | -399.66 Million USD | 214.028% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 1302185.586% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -929961.133% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 94.705% |
| Denali Therapeutics Inc. | -93.34 Million USD | 588.221% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1819453.886% |
| Veru Inc. | 7.56 Million USD | -5923.451% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 301907.917% |
| Cingulate Inc. | -582.91 Thousand USD | 78280.8% |
| Passage Bio, Inc. | -3.72 Million USD | 12347.513% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 3783975.415% |
| Exicure, Inc. | -1.42 Million USD | 32125.998% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 119089.544% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -16760.154% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 88992.564% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 304718.069% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 869.736% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -116454.976% |
| OmniAb, Inc. | 14.66 Million USD | -3007.179% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -2179.448% |
| Lipocine Inc. | -2.85 Million USD | 16085.936% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 24827.616% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 8088.255% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 30355.107% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -505.09% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 701223.008% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -440.631% |
| Ocugen, Inc. | -33.53 Million USD | 1458.887% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 14512.712% |
| Q32 Bio Inc. | 578 Thousand USD | -78746.013% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 172073.568% |
| Alumis Inc. Common Stock | -1.28 Million USD | 35592.987% |
| Equillium, Inc. | 35.95 Million USD | -1167.395% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 26797.713% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -90922.383% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 11024046.662% |
| Dominari Holdings Inc. | 2.03 Million USD | -22250.66% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 248493.455% |
| vTv Therapeutics Inc. | -13.59 Million USD | 3452.188% |
| Bio-Techne Corporation | 773.07 Million USD | 41.05% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -2531.387% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 1.097% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 39084.598% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 2000.459% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -3796.127% |
| Nkarta, Inc. | -5.86 Million USD | 7865.036% |
| BioCardia, Inc. | -7.24 Million USD | 6386.798% |
| Iterum Therapeutics plc | -1.75 Million USD | 26141.712% |